BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17726548)

  • 1. Elevated cyclin E level in human clear cell renal cell carcinoma: possible causes and consequences.
    Nauman A; Turowska O; Poplawski P; Master A; Tanski Z; Puzianowska-Kuznicka M
    Acta Biochim Pol; 2007; 54(3):595-602. PubMed ID: 17726548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
    Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
    Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors.
    Salon C; Merdzhanova G; Brambilla C; Brambilla E; Gazzeri S; Eymin B
    Oncogene; 2007 Oct; 26(48):6927-36. PubMed ID: 17471231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma.
    Sutter T; Dansranjavin T; Lubinski J; Debniak T; Giannakudis J; Hoang-Vu C; Dralle H
    Int J Colorectal Dis; 2002 Nov; 17(6):374-80. PubMed ID: 12355212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of p21WAF1, p27KIP1 and cyclin E in ameloblastoma].
    Zhong M; Liu J; Gong YB; Liu JD; Wang J; Zhang B
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):306-9. PubMed ID: 16191374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a cyclin E1 isoform in mice is correlated with the quiescent cell cycle status of hepatocytes in vivo.
    Zschemisch NH; Liedtke C; Dierssen U; Nevzorova YA; Wüstefeld T; Borlak J; Manns MP; Trautwein C
    Hepatology; 2006 Jul; 44(1):164-73. PubMed ID: 16799991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
    Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.
    Schild C; Wirth M; Reichert M; Schmid RM; Saur D; Schneider G
    Mol Carcinog; 2009 Dec; 48(12):1149-58. PubMed ID: 19603422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression.
    Koutsami MK; Tsantoulis PK; Kouloukoussa M; Apostolopoulou K; Pateras IS; Spartinou Z; Drougou A; Evangelou K; Kittas C; Bartkova J; Bartek J; Gorgoulis VG
    J Pathol; 2006 Aug; 209(4):512-21. PubMed ID: 16739112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
    Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
    Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
    Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
    Shimizu Y; Takeuchi T; Mita S; Mizuguchi K; Kiyono T; Inoue M; Kyo S
    Mol Hum Reprod; 2009 Oct; 15(10):693-701. PubMed ID: 19502247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival.
    Milne AN; Carvalho R; Jansen M; Kranenbarg EK; van de Velde CJ; Morsink FM; Musler AR; Weterman MA; Offerhaus GJ
    J Clin Pathol; 2008 Mar; 61(3):311-6. PubMed ID: 18305181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
    Todd MC; Spruill SC; Meerbrey KL
    Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of cyclin E in low-risk node negative breast cancer.
    Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
    Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma].
    Struckmann K; Mertz K; Staller P; Krek W; Schraml P; Moch H
    Verh Dtsch Ges Pathol; 2005; 89():178-83. PubMed ID: 18035688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.